Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Clarke, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, A. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 3, 435-441, March 2000
© 2000 Oxford University Press


Carcinogenesis

Manipulating the germline: its impact on the study of carcinogenesis

Alan R. Clarke

Cardiff School of Biosciences, Cardiff University, PO Box 911, Cardiff CF10 3US, UK

Over the past two decades, the mouse has established itself as the primary organism in which to investigate the fundamental mechanisms of carcinogenesis and to model human neoplasia. The principal reason underlying such dominance almost certainly arises out of our ever increasing ability to manipulate the murine germline. Over the past 20 years we have moved from a position where animal models arose either spontaneously or were generated through exposure to carcinogen to a position in which it is possible to create and study precise mutations of choice. The most recent advances in inducible and conditional technologies now open the possibility for both temporal and tissue-specific gene manipulation. Each of these technological breakthroughs has facilitated significant steps forward in our understanding of the genetic basis of tumorigenesis. This review will highlight some of the major advances in the production and use of murine models of neoplasia over the last two decades.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. Suggitt and M. C. Bibby
50 Years of Preclinical Anticancer Drug Screening: Empirical to Target-Driven Approaches
Clin. Cancer Res., February 1, 2005; 11(3): 971 - 981.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Harrison, A.-M. Ketchen, N. J. Redhead, M. J. O'Sullivan, and D. W. Melton
Replication Failure, Genome Instability, and Increased Cancer Susceptibility in Mice with a Point Mutation in the DNA Ligase I Gene
Cancer Res., July 15, 2002; 62(14): 4065 - 4074.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Balmain and C. C.Harris
Carcinogenesis in mouse and human cells: parallels and paradoxes
Carcinogenesis, March 1, 2000; 21(3): 371 - 377.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.